Clinical Indications of Intravenous Immunoglobulin Use in Pediatric Infectious Diseases Clinic

Aydin Z. G., Tanir G.

JOURNAL OF PEDIATRIC INFECTION, vol.11, no.4, pp.166-171, 2017 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.5578/ced.201741
  • Journal Name: JOURNAL OF PEDIATRIC INFECTION
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.166-171
  • Karadeniz Technical University Affiliated: Yes

Abstract

Objective: Intravenous immunoglobulin (IVIG) is a human polyclonal IgG preparation developed for the treatment of patients with primary immunodeficiency (PID). Because of the anti-inflammatory and immunomodulatory effects of IVIG, beyond PID now IVIG is widely used in autoimmune and inflammatory diseases. The aim of this study was to determine the demographic characteristics of patients treated with IVIG treatment in the pediatric infectious diseases clinic, and to evaluate the indications, side effects and treatment outcomes of IVIG treatment.